Latest research

Therapix Biosciences

Two new cannabinoid programs

Update | Pharmaceutical & healthcare | 17/11/2017

Therapix is expanding its cannabinoid-based clinical pipeline beyond neurological disorders to potentially treat obstructive sleep apnea (OSA), a chronic…

Blancco Technology Group

Rebasing the business

Update | Technology | 17/11/2017

After a difficult six months for Blancco, we believe that management has stabilised the business and put it on a course for sustainable growth. A focus…

TXT e-solutions

Well funded for growth

Outlook | Technology | 17/11/2017

TXT has reported its first set of results showing TXT Next as a standalone business. We have revised our forecasts to reflect the new structure of the…


Irons in the fire

Update | Technology | 17/11/2017

TerraNet (TERRNT) is an early-stage software group with a range of products under development deriving principally from its industrial IoT, chip integration…

Finsbury Growth & Income Trust

Glory, glory, Man United

Review | Investment Companies | 16/11/2017

Finsbury Growth & Income Trust (FGT) aims to generate long-term capital and income growth from a concentrated portfolio of primarily UK equities. Manager…